Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatocellular carcinoma recurrence after direct-acting antivirals
PACTR201708002452985Unknown
- Sponsor
- Alexandria Main University Hospital
- Start
- Aug 2017
- Countries
- 1
01
Overview
Open-label trial in hepatitis C virus infection (2 arms), sponsored by Alexandria Main University Hospital. Primary endpoint: Hepatocellular carcinoma recurrence. Status: unknown.
02
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on PACTR201708002452985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201708002452985.